In a year of many global market challenges that have impacted the automotive industry, the MEMA Original Equipment Suppliers Annual Conference held ...

As President-elect Donald Trump nears his return to the White House, the U.S. Navy’s nuclear-armed sea-launched cruise ...

NEW YORK-- ( BUSINESS WIRE )--Hess Corporation (NYSE: HES) announced today that John Hess, Chief Executive Officer, will ...

On Monday, TransUnion (TRU) stock saw a modest uptick, ending the day at $96.93 which represents a slight increase of $1.27 or 1.33% from the prior close of $95.66. The stock opened at $95.91 and ...

Best Genomics Stocks To Buy Right Now. Genomics is the study of genes and how they function. Many rapidly growing companies ...

Wolfe Research downgraded Matson (MATX) to Peer Perform from Outperform. The firm cites valuation for the downgrade. Matson has materially ...

The U.S. Air Force Research Laboratory has chosen California's Yates Electrospace Corp. to build six CLS-200 autonomous, ...

On Friday, Gilead Sciences, Inc. (GILD) stock saw a decline, ending the day at $88.4 which represents a decrease of $-3.71 or -4.03% from the prior close of $92.11. The stock opened at $91.71 and ...

Fintel reports that on November 18, 2024, Wolfe Research downgraded their outlook for Matson (NYSE:MATX) from Outperform to ...

Fintel reports that on November 15, 2024, Wolfe Research initiated coverage of BioMarin Pharmaceutical (NasdaqGS:BMRN) with a ...

Wolfe projects a positive outlook for Pharma & Large-Cap Biotech stocks despite potential policy changes as part of Make America Healthy Again movement. Read more here.

Wolfe Research analyst Alexandria Hammond initiated coverage of Johnson & Johnson with an Outperform rating and $190 price target ...